Opium use and gastrointestinal cancers: a systematic review and meta-analysis study
Gastroenterology and Hepatology from Bed to Bench,
Vol. 17 No. 2 (2024),
14 Farvardin 2024
https://doi.org/10.22037/ghfbb.v17i2.2882
Abstract
Aim: The current systematic review and meta-analysis aimed to assess the association between Gastrointestinal (GI) cancers and opium use.
Background: GI malignancies are a global public health issue and are associated with many risk factors including genetic and lifestyle factors.
Methods: PubMed, Web of Science, Embase and Scopus and the Google Scholar search engine in addition to Persian databases including Magiran and SID were searched using relevant keywords. The associations of opium use, long duration of opium use, high daily amount opium use and high cumulative opium use and GI cancer and various subtypes of GI cancers were estimated and pooled in format of odds ratios (OR) and their corresponding 95% confidence intervals (CI) with a random effects model.
Results: 22 articles that were published between 1983 and 2022 entered the analyses. There were significant relationships between opium use based on crude effect sizes (OR: 2.53, 1.95-3.29) and adjusted effect sizes (OR: 2.64, 1.99-3.51), high daily opium use (or: 3.41, 1.92-6.06), long duration of opium use (OR: 3.03, 1.90-4.84) and high cumulative opium use (OR: 3.88, 2.35-6.41), all compared to never opium use, and GI cancer. The results were not sensitive to sensitivity analyses and no influential publication biases were found in these analyses.
Conclusion: Our meta-analysis showed that opium use could be associated with increased risk of overall and some particular GI cancers including oropharyngeal, gastric, pancreatic and colorectal cancers. Opium use as a potentially modifiable factor, therefore, should be more emphasized.
- Opium, Gastrointestinal tract, Cancer, Meta-analysis
How to Cite
References
Cancer [https://www.who.int/news-room/fact-sheets/detail/cancer]
Mattiuzzi C, Lippi G: Current Cancer Epidemiology. Journal of epidemiology and global health 2019, 9(4):217-222.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2021.
Onyoh EF, Hsu W-F, Chang L-C, Lee Y-C, Wu M-S, Chiu H-M: The rise of colorectal cancer in Asia: epidemiology, screening, and management. Current gastroenterology reports 2019, 21(8):1-10.
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F: Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017, 66(4):683-691.
Huang F-L, Yu S-J: Esophageal cancer: risk factors, genetic association, and treatment. Asian journal of surgery 2018, 41(3):210-215.
Murphy N, Jenab M, Gunter MJ: Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. Nature Reviews Gastroenterology & Hepatology 2018, 15(11):659-670.
Ocvirk S, Wilson AS, Appolonia CN, Thomas TK, O’Keefe SJ: Fiber, fat, and colorectal cancer: new insight into modifiable dietary risk factors. Current gastroenterology reports 2019, 21(11):1-7.
Cook-Mozaffari P, Azordegan F, Day N, Ressicaud A, Sabai C, Aramesh B: Oesophageal cancer studies in the Caspian Littoral of Iran: results of a case-control study. British journal of cancer 1979, 39(3):293-309.
Sheikh M, Shakeri R, Poustchi H, Pourshams A, Etemadi A, Islami F, Khoshnia M, Gharavi A, Roshandel G, Khademi H: Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. The Lancet Global Health 2020, 8(5):e649-e660.
Rashidian H, Zendehdel K, Kamangar F, Malekzadeh R, Haghdoost AA: An ecological study of the association between opiate use and incidence of cancers. Addiction & health 2016, 8(4):252.
Mansouri M, Naghshi S, Parsaeian M, S GS, Poustchi H, Momayez Sanat Z, Sadeghi O, Pourshams A: Opium Use and Cancer Risk: A Comprehensive Systematic Review and Meta-Analysis of Observational Studies. International journal of clinical practice 2022, 2022:5397449.
Bidary MZ, Sahranavard M, Rezayat AA, Omranzadeh A, Hoseiny SH, Kabirian A, Sahebkar A: Opium as a carcinogen: A systematic review and meta-analysis. EClinicalMedicine 2021, 33:100768.
Shokri-Shirvani J, Kordinejad B, Meftah N, Amani N: Demographic Characteristics, Clinical Symptoms and Endoscopic Findings in Patients with Gastric Ulcer versus Gastric Cancer. Journal of Babol University of Medical Sciences 2013, 15(5):59-64.
Pournaghi S-J, Hojjat SK, Barazandeh Noveyri F, Tavakkoli Ghouchani H, Ahmadi A, Hamedi A, Rahimi J, Mohamaddoust H, Lashkardoost H: Tobacco consumption, opium use, alcohol drinking and the risk of esophageal cancer in North Khorasan, Iran. Journal of Substance Use 2019, 24(1):105-109.
Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, Marjani HA, Merat S, Nasseri-Moghaddam S, Pourshams A et al: Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer 2004, 90(7):1402-1406.
Collatuzzo G, Seyyedsalehi MS, Rezaeianzadeh A, Marzban M, Rashidian H, Hadji M, Kamangar F, Etemadi A, Pukkala E, Zendehdel K et al: Consumption of Yoghurt and Other Dairy Products and Risk of Colorectal Cancer in Iran: The IROPICAN Study. Nutrients 2022, 14(12).
Marzban M, Mohebbi E, Haghdoost A, Aryaie M, Zahedi MJ, Khazaei Z, Gholizade M, Naghibzadeh-Tahami A: Opium Use and the Risk of Liver Cancer: A Case-Control Study. Cancer prevention research (Philadelphia, Pa) 2023, 16(1):29-35.
Momayez Sanat Z, Masoudi S, Mansouri M, Ghamarzad Shishavan N, Jameshorani M, Pourshams A: Diabetes Mellitus, Obesity, and Risk of Pancreatic Ductal Adenocarcinoma: a Large Case-Control Study from Iran. Middle East journal of digestive diseases 2021, 13(1):15-20.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 2021, 372:n71.
Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology 2010, 25(9):603-605.
Marzban M, Mohebbi E, Haghdoost A, Aryaie M, Zahedi MJ, Khazaei Z, Gholizade M, Naghibzadeh-Tahami A: Opium Use and the Risk of Liver Cancer: A Case-Control Study. Cancer prevention research (Philadelphia, Pa) 2022.
Naghibzadeh-Tahami A, Marzban M, Yazdi-Feyzabadi V, Khazaei Z, Zahedi MJ, Moazed V, Haghdoost AA: Opium use as an independent risk factor for pancreatic cancer: A case-control study. Cancer epidemiology 2021, 75:102017.
Mohebbi E, Hadji M, Rashidian H, Rezaianzadeh A, Marzban M, Haghdoost AA, Naghibzadeh Tahami A, Moradi A, Gholipour M, Najafi F et al: Opium use and the risk of head and neck squamous cell carcinoma. International journal of cancer 2021, 148(5):1066-1076.
Sheikh M, Shakeri R, Poustchi H, Pourshams A, Etemadi A, Islami F, Khoshnia M, Gharavi A, Roshandel G, Khademi H et al: Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. The Lancet Global Health 2020, 8(5):e649-e660.
Vazirinejad R, Najafipour R, Rezaeian M, Ghazizadeh A, Doost Mohammadi F: Opium and risk of gastrointestinal cancer: a case-control study. Turkish journal of medical sciences 2020, 50(4):697-705.
Pournaghi S-J, Hojjat SK, Barazandeh Noveyri F, Tavakkoli Ghouchani H, Ahmadi A, Hamedi A, Rahimi J, Mohamaddoust H, Lashkardoost HJJoSU: Tobacco consumption, opium use, alcohol drinking and the risk of esophageal cancer in North Khorasan, Iran. 2019, 24(1):105-109.
lankarani KB, Khosravizadegan Z, Naghibzadeh-Tahami A, Akbari M, Khodadost M, Honarvar B, Khodadost B, Goodarzi F, Jokari K, Akbari M et al: Opium Use and Risk of Lower Gastrointestinal Cancers: Population-Based Case-Control Study in South of Iran. 2017, 10(6):e8227.
Bakhshaee M, Raziee HR, Afshari R, Amali A, Roopoosh M, Lotfizadeh A: Opium Addiction and Risk of Laryngeal and Esophageal Carcinoma %J Iranian Journal of Otorhinolaryngology. 2017, 29(1):19-22.
Shakeri R, Kamangar F, Mohamadnejad M, Tabrizi R, Zamani F, Mohamadkhani A, Nikfam S, Nikmanesh A, Sotoudeh M, Sotoudehmanesh R et al: Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer. Medicine 2016, 95(28):e3922.
Ahmad N-T, Vahid YF, Narges K, Ahad A-A, Hosniyeh A, Vahid Reza B, Mohammad M-J, Masoud Z, Mohammad Javad Z, Mahmoud A-A et al: Can Opium Use Contribute to a Higher Risk of Colorectal Cancers? A Matched Case-control Study in Iran. Iranian Journal of Public Health 2016, 45(10).
Razmpa E, Saedi B, Motiee-langroudi M, Garajei A, Hoseinpor S, Motamedi MH: Opium usage as an etiologic factor of oral cavity cancer. The Journal of craniofacial surgery 2014, 25(5):e505-507.
Hakami R, Etemadi A, Kamangar F, Pourshams A, Mohtadinia J, Firoozi MS, Birkett N, Boffetta P, Dawsey SM, Malekzadeh R: Cooking methods and esophageal squamous cell carcinoma in high-risk areas of Iran. Nutrition and cancer 2014, 66(3):500-505.
Naghibzadeh Tahami A, Khanjani N, Yazdi Feyzabadi V, Varzandeh M, Haghdoost AA: Opium as a risk factor for upper gastrointestinal cancers: a population-based case-control study in Iran. Archives of Iranian medicine 2014, 17(1):2-6.
Sadjadi A, Derakhshan MH, Yazdanbod A, Boreiri M, Parsaeian M, Babaei M, Alimohammadian M, Samadi F, Etemadi A, Pourfarzi F et al: Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions. International journal of cancer 2014, 134(1):181-188.
Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Islami F, Pourshams A, Pawlita M, Boffetta P et al: Opium: an emerging risk factor for gastric adenocarcinoma. International journal of cancer 2013, 133(2):455-461.
Shokri-Shirvani J, Kordinejad B, Meftah N, Amani N: Demographic Characteristics, Clinical Symptoms and Endoscopic Findings in Patients with Gastric Ulcer versus Gastric Cancer. Journal of Babol University of Medical Sciences 2013, 15:59-64.
Shakeri R, Kamangar F, Nasrollahzadeh D, Nouraie M, Khademi H, Etemadi A, Islami F, Marjani H, Fahimi S, Sepehr A et al: Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies. PloS one 2012, 7(3):e32711.
Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, Shakeri R, Pourshams A, Marjani HA, Nouraie M et al: Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. British journal of cancer 2008, 98(11):1857-1863.
Fahmy MS, Sadeghi A, Behmard S: Epidemiologic study of oral cancer in Fars Province, Iran. Community dentistry and oral epidemiology 1983, 11(1):50-58.
Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Islami F, Pourshams A, Pawlita M, Boffetta P: Opium: an emerging risk factor for gastric adenocarcinoma. International journal of cancer 2013, 133(2):455-461.
Nakhaee N, Divsalar K, Meimandi MS, Dabiri S: Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: a pilot study in Iran. Substance use & misuse 2008, 43(3-4):513-520.
Zarghami M: Iranian common attitude toward opium consumption. Iranian journal of psychiatry and behavioral sciences 2015, 9(2).
Masjedi MR, Naghan PA, Taslimi S, Yousefifard M, Ebrahimi SM, Khosravi A, Karimi S, Hosseini M, Mortaz E: Opium could be considered an independent risk factor for lung cancer: a case-control study. Respiration 2013, 85(2):112-118.
Maisonneuve P, Lowenfels AB: Risk factors for pancreatic cancer: a summary review of meta-analytical studies. International journal of epidemiology 2015, 44(1):186-198.
Lucenteforte E, La Vecchia C, Silverman D, Petersen G, Bracci P, Ji Ba, Bosetti C, Li D, Gallinger S, Miller A: Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case–Control Consortium (PanC4). Annals of oncology 2012, 23(2):374-382.
Ribeiro Pinto L, Swann PF: Opium and oesophageal cancer: effect of morphine and opium on the metabolism of N-nitrosodimethylamine and N-nitrosodiethylamine in the rat. Carcinogenesis 1997, 18(2):365-369.
Hosseini SY, Safarinejad MR, Amini E, Hooshyar H: Opium consumption and risk of bladder cancer: a case-control analysis. In: Urologic Oncology: Seminars and Original Investigations: 2010: Elsevier; 2010: 610-616.
Friesen M, O'neill IK, Malaveille C, Garren L, Hautefeuille A, Bartsch H: Substituted hydroxyphenanthrenes in opium pyrolysates implicated in oesophageal cancer in Iran: structures and in vitro metabolic activation of a novel class of mutagens. Carcinogenesis 1987, 8(10):1423-1432.
Zou L, Zhong R, Shen N, Chen W, Zhu B, Ke J, Lu X, Zhang T, Lou J, Wang Z: Non-linear dose–response relationship between cigarette smoking and pancreatic cancer risk: evidence from a meta-analysis of 42 observational studies. European journal of cancer 2014, 50(1):193-203.
Hewer T, Rose E, Ghadirian P, Castegnaro M, Malaveille C, Bartsch H, Day N: Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus. The Lancet 1978, 312(8088):494-496.
Perry P, Thomson E, Day N, Bartsch H: Induction of SCE by opium pyrolysates in CHO cells and human peripheral blood lymphocytes. Carcinogenesis 1983, 4(2):227-230.
Vallejo R, de Leon-Casasola O, Benyamin R: Opioid therapy and immunosuppression: a review. American journal of therapeutics 2004, 11(5):354-365.
Bosetti C, Lucenteforte E, Silverman D, Petersen G, Bracci P, Ji B, Negri E, Li D, Risch H, Olson S: Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Annals of oncology 2012, 23(7):1880-1888.
Kamangar F, Malekzadeh R, Dawsey SM, Saeidi F: Esophageal cancer in Northeastern Iran: a review. 2007.
Fimiani C, Arcuri E, Santoni A, Rialas C, Bilfinger T, Peter D, Salzet B, Stefano G: μ3 Opiate receptor expression in lung and lung carcinoma: ligand binding and coupling to nitric oxide release. Cancer letters 1999, 146(1):45-51.
Bosshart H: Morphine and cancer progression: hydrogen peroxide points to need for more research. Journal of opioid management 2011, 7(2):93-96.
- Abstract Viewed: 94 times
- Supplementary Downloaded: 7 times